- Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy
-
Phan H, Weideman RA, Cipher DJ, Feagins LA
- KMID: 2504583
- Intest Res.
- 2020 Jul;18(3):282-288.
- doi: 10.5217/ir.2019.09140
Background/Aims: Safety for tumor necrosis factor inhibitors (TNFi) in cancer has been focused on risk of incident malignancies, but studies on prognostic effects have been scarce. We determined survival and... -
- CITED
-
- Close
- SHARE
-
- Close
